9 Podcast Episodes
Carl June
Carl June
Carl June is a co-founder of Tmunity Therapeutics, and a professor in immunotherapy at the University of Pennsylvania, w... Read more
1 Jun 2021
•
1hr 5mins
Ep. 4: “Therapeutic T Cell Engineering” Featuring Drs. Carl June and Philipp Rommel
Ep. 4: “Therapeutic T Cell Engineering” Featuring Drs. Carl June and Philipp Rommel
Guests:Dr. Carl June is the Richard W. Vague Professor in Immunology at the University of Pennsylvania, Director of the ... Read more
11 May 2021
•
1hr 13mins
Healthcare Panel with Doctors Carl June, David Porter & Josh Bilenker
Healthcare Panel with Doctors Carl June, David Porter & Josh Bilenker
Immunologist Dr. Carl June, medical oncologist Dr. David Porter, and Loxo Oncology at Lilly CEO Dr. Josh Bilenker gather... Read more
13 Oct 2020
•
56mins
A "living drug" that could change the way we treat cancer | Carl June
A "living drug" that could change the way we treat cancer | Carl June
Carl June is the pioneer behind CAR T-cell therapy: a groundbreaking cancer treatment that supercharges part of a patien... Read more
10 Sep 2019
•
15mins
암 치료법을 바꿀 수 있는 "살아있는 약" | 칼 준(Carl June)
암 치료법을 바꿀 수 있는 "살아있는 약" | 칼 준(Carl June)
칼 준(Carl June) 박사는 환자의 면역 체계 일부를 과급시켜 종양 세포를 공격해 죽이는 획기적인 CAR-T 세포 치료법의 선구자입니다. 본 강연에서는 30년 간의 연구를 통해 한 때 불치병으로 여겼던 백혈병 ... Read more
10 Sep 2019
•
15mins
Uma "droga viva" que pode mudar a maneira como tratamos o câncer | Carl June
Uma "droga viva" que pode mudar a maneira como tratamos o câncer | Carl June
Carl June é o pioneiro da terapia com células T CAR: um tratamento inovador para o câncer que sobrecarrega parte do sist... Read more
10 Sep 2019
•
15mins
Un nuevo fármaco biológico que podría cambiar nuestra forma de tratar el cáncer | Carl June
Un nuevo fármaco biológico que podría cambiar nuestra forma de tratar el cáncer | Carl June
Carl June es el pionero de la terapia de células T con CAR: un tratamiento revolucionario para el cáncer que potencia pa... Read more
10 Sep 2019
•
15mins
Ein "lebendes Medikament", das die Krebsbehandlung revolutionieren könnte | Carl June
Ein "lebendes Medikament", das die Krebsbehandlung revolutionieren könnte | Carl June
Carl June ist der Pionier hinter der CAR-T-Zelltherapie, einer bahnbrechenden Krebsbehandlung, bei der Immunzellen des P... Read more
10 Sep 2019
•
15mins
NEJM Interview: Dr. Carl June on chimeric antigen receptor therapy.
NEJM Interview: Dr. Carl June on chimeric antigen receptor therapy.
Dr. Carl June is the director of the Center for Cellular Immunotherapies at the University of Pennsylvania Perelman Scho... Read more
4 Jul 2018
•
9mins